Core Laboratories Inc. 0Q82.L Stock
Core Laboratories Inc. Price Chart
Core Laboratories Inc. 0Q82.L Financial and Trading Overview
| Core Laboratories Inc. stock price | 18.4 EUR |
| Previous Close | 20 EUR |
| Open | 0 EUR |
| Bid | 0 EUR x N/A |
| Ask | 0 EUR x N/A |
| Day's Range | 0 - 0 EUR |
| 52 Week Range | 0 - 0 EUR |
| Volume | 0 EUR |
| Avg. Volume | N/A |
| Market Cap | N/A |
| Beta (5Y Monthly) | 2.668191 |
| PE Ratio (TTM) | 0.9533679 |
| EPS (TTM) | 0.19 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
0Q82.L Valuation Measures
| Enterprise Value | 1.08B EUR |
| Trailing P/E | 0.9533679 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 4.391408 |
| Enterprise Value/Revenue | 2.153 |
| Enterprise Value/EBITDA | 16.539 |
Trading Information
Core Laboratories Inc. Stock Price History
| Beta (5Y Monthly) | 2.668191 |
| 52-Week Change | N/A |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0 EUR |
| 52 Week Low | 0 EUR |
| 50-Day Moving Average | N/A |
| 200-Day Moving Average | N/A |
0Q82.L Share Statistics
| Avg. Volume (3 month) | N/A |
| Avg. Daily Volume (10-Days) | N/A |
| Shares Outstanding | N/A |
| Float | 46.38M |
| Short Ratio | N/A |
| % Held by Insiders | N/A |
| % Held by Institutions | N/A |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0.04 |
| Trailing Annual Dividend Yield | 0.19% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 4.71% |
| Operating Margin (ttm) | 9.70% |
| Gross Margin | 20.79% |
| EBITDA Margin | 13.01% |
Management Effectiveness
| Return on Assets (ttm) | 5.17% |
| Return on Equity (ttm) | 13.06% |
Income Statement
| Revenue (ttm) | 502.79M EUR |
| Revenue Per Share (ttm) | 10.83 EUR |
| Quarterly Revenue Growth (yoy) | 11.30% |
| Gross Profit (ttm) | 96.08M EUR |
| EBITDA | 65.45M EUR |
| Net Income Avi to Common (ttm) | 23.71M EUR |
| Diluted EPS (ttm) | 0.193 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 16.29M EUR |
| Total Cash Per Share (mrq) | 0.35 EUR |
| Total Debt (mrq) | 235.31M EUR |
| Total Debt/Equity (mrq) | 117.56 EUR |
| Current Ratio (mrq) | 2.384 |
| Book Value Per Share (mrq) | 4.19 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 16.5M EUR |
| Levered Free Cash Flow (ttm) | 5.86M EUR |
Profile of Core Laboratories Inc.
| Country | United Kingdom |
| State | TX |
| City | Houston |
| Address | 6316 Windfern Road |
| ZIP | 77040 |
| Phone | N/A |
| Website | https://www.corelab.com |
| Industry | |
| Sector(s) | |
| Full Time Employees | 3600 |
Core Laboratories Inc. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock, reservoir fluid, and gas samples to enhance production and improve recovery of oil and gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and oil delivered products; and proprietary and joint industry studies, as well as services that support carbon capture, utilization and storage, hydrogen storage, geothermal projects, and the evaluation and appraisal of mining activities. The Production Enhancement segment provides services and products relating to reservoir well completions, perforations, stimulations, and production. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. The company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. The company was founded in 1936 and is based in Houston, Texas.
Q&A For Core Laboratories Inc. Stock
What is a current 0Q82.L stock price?
Core Laboratories Inc. 0Q82.L stock price today per share is 18.4 EUR.
How to purchase Core Laboratories Inc. stock?
You can buy 0Q82.L shares on the LSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Core Laboratories Inc.?
The stock symbol or ticker of Core Laboratories Inc. is 0Q82.L.
How many shares does Core Laboratories Inc. have in circulation?
The max supply of Core Laboratories Inc. shares is 0.
What is Core Laboratories Inc. Price to Earnings Ratio (PE Ratio)?
Core Laboratories Inc. PE Ratio is 0.95336790 now.
What was Core Laboratories Inc. earnings per share over the trailing 12 months (TTM)?
Core Laboratories Inc. EPS is 0.19 EUR over the trailing 12 months.